FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in Denver on Saturday, March 6, 2021. On Thursday, May 5, 2022, U.S. regulators strictly limited who can receive this vaccine due to a rare but serious risk of blood clots. (David Zalubowski/AP, File)

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in Denver on Saturday, March 6, 2021. On Thursday, May 5, 2022, U.S. regulators strictly limited who can receive this vaccine due to a rare but serious risk of blood clots. (David Zalubowski/AP, File)

To view this content you must be logged in as a subscriber.
Already have a digital account? Log in here
4 WEEKS
$7

UNLIMITED

DIGITAL ACCESS

4 WEEKS

1 YEAR
$84

UNLIMITED

DIGITAL ACCESS

FOR 12 MONTHS

DAY PASS
$2.99

UNLIMITED

DIGITAL ACCESS

FOR 24 HOURS

Plans include full website access, e-Edition and exclusive online extras.
Print and Digital combo plans also available.
ALREADY A PRINT SUBSCRIBER?
dcourier subscribe logo
Donate Report a Typo Contact
Most Read
Event Calendar
Event Calendar link
Submit Event